A*STAR's Conference @ SWITCH 2024

Dr Joe Yeong Poh Sheng (MBBS, PhD) is a Principal Investigator in pathology at the Institute of Molecular and Cell Biology (IMCB, A*STAR) and holds a joint appointment in the Department of Anatomical Pathology, Singapore General Hospital (SGH). He has undergone multidisciplinary training for clinical (MBBS), immunology (PhD) and histopathology (British Royal College of Pathologist (RCPath), Associateship), and possess more than 10 years of translational research experience.

He is the pioneer and key opinion leader in automation of quantitative multiplex (fluorescence-) immunohistochemistry (m-IHC/IF), utilising clinical autostainers to study and quantitate tumour immune microenvironment. He has established an integrative m-IHC/IF pathology platform in the Department of Anatomical Pathology, SGH which is the first of its kind in Asia-Pacific (APAC) region; providing a one-stop solution for scientists, clinicians, immunologists and pathologists to synergise their expertise in biomarker discovery and translation for clinical practice. This approach displays the importance of the emerging new branch of diagnostic pathology – immunopathology.

Dean HO is currently Provost’s Chair Professor and Head of the Department of Biomedical Engineering in the College of Design and Engineering, Director of The Institute for Digital Medicine (WisDM) at the Yong Loo Lin School of Medicine, and Director of The N.1 Institute for Health (N.1) at the National University of Singapore.

He and collaborators successfully developed and validated CURATE.AI, a powerful artificial intelligence platform that personalizes human treatment for a broad spectrum of indications ranging from oncology, to digital therapeutics and infectious diseases, among others. His team also developed IDentif.AI to optimise combination therapy design against SARS-CoV-2 and to address antimicrobial resistance. Recently, his team unveiled WisDM Green, a technology platform to sustainably address food security and optimise yield while preserving nutritional content.

Sebastian Maurer-Stroh studied theoretical biochemistry at the University of Vienna and wrote his master and PhD thesis at the Institute of Molecular Pathology (IMP). After FEBS and Marie Curie fellowships at the VIB-SWITCH lab in Brussels, he has been leading the sequence analytics portfolio in the A*STAR Bioinformatics Institute (BII) since 2007 and Infectious Disease Programme since 2010. He is the Executive Director of BII since January 2021. His computational team is well known for successes at the public-private interface in Singapore from Precision Medicine to Consumer Product and Food Safety and of course for his critical contributions to national and global viral pathogen surveillance through the GISAID data science initiative that has become the single most important source for virus outbreak data sharing and analysis in this pandemic powering public health responses globally.

Dr Rick Goh is the Director of Computing & Intelligence (CI) Department at the Institute of High Performance Computing (IHPC), a research institute under the Agency for Science, Technology and Research (A*STAR) Rick leads a team of scientists and engineers in performing world-leading scientific research, developing technology to commercialisation, and engaging and collaborating with industry in Knowledge-Driven Artificial Intelligence (AI), High Performance, Distributed & Efficient Computing, and Complex Systems Modelling and Multi-scale Optimisation.

Mr David Vu is Chief Operating Officer, DxD Hub and Co-Lead, Digital Health Accelerator. Prior to joining DxD Hub, David was Senior Vice President for Healthcare at ST Engineering where he focused on Digital Health mergers and acquisitions. He also has nearly 20 years with General Electric in a variety of Operations, Finance, and Commercial roles including Vice President and Chief Commercial Officer for GE Healthcare Digital in Asia Pacific. In this role he led a regional sales, marketing, and professional services team responsible for GE’s suite of clinical workflow solutions deployed in some of Asia’s premier hospitals. During David’s tenure, GE Healthcare was recognised by Frost and Sullivan, a global market research firm, as Asia-Pacific Healthcare IT company of the year from 2014-2017, and Southeast Asia Radiology Informatics company of the year in 2017.

Adj. Professor Ngiam Kee Yuan is a clinician innovator with publications ranging from clinical science to artificial intelligence. He is among the world's top 2% of highly-cited researchers by Stanford University-Elsevier survey in 2023. His professional interests are innovations in surgery and artificial intelligence (AI) in healthcare. He has founded numerous platforms and programs, including the DISCOVERY AI, ENDEAVOUR AI, the NUHS Holomedicine and MiSSi cloud robotics program. He is a recipient of multiple grants including the Ministry of Health Innovation grant, HOIC Enterprise Singapore grant, and the Infocomm Media Development Authority (IMDA) 5G grant. He holds multiple patents in surgery and AI technology.

Mr. Lijoy George is the Assistant Vice President and Head of Digital Health at DxD Hub, as well as the Co-Lead of the Digital Health Accelerator. Prior to joining DxD Hub, Lijoy spent 16 years at Philips Singapore in various roles, including IT Business Partner, Transition and Adoption Manager for APAC, Senior Healthcare Project Manager for ASEAN, and Healthcare Operations Manager for ASEAN. In these roles, he was responsible for the Healthcare Informatics portfolio operations, which included optimizing clinical workflows for cardiology, radiology, advanced imaging solutions, and service maintenance through continuous improvement initiatives. Lijoy is certified in Lean, Green Belt (Six Sigma), and Project Management (PMP). He holds a Bachelor of Science degree in Mathematics and Statistics, a Master’s in Computer Applications from the University of Madras in India, and a Master’s in Business Administration from the University of Southern Queensland in Australia.

Jayne is leading the quantum algorithms and theories team at A*Star's QInC. She has previously worked in the quantum tech industry as a principal scientist and technical product manager for the quantum software company, Horizon Quantum Computing, and in academia as a research fellow at the Centre for Quantum Technologies in Singapore. Jayne holds a PhD in theoretical physics from the University of Melbourne (circa 2012). She has worked extensively in the field of quantum information, and quantum computing both on developing new protocols as well as the design of quantum programming languages and software.